Cresco Labs Inc (CRLBF)
1.95
-0.11
(-5.34%)
USD |
OTCM |
Apr 25, 16:00
Cresco Labs Profit Margin (Quarterly): 1.40% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.40% |
| September 30, 2023 | -60.65% |
| June 30, 2023 | -18.46% |
| March 31, 2023 | -13.41% |
| December 31, 2022 | -80.84% |
| September 30, 2022 | -4.65% |
| June 30, 2022 | -6.20% |
| March 31, 2022 | -12.77% |
| December 31, 2021 | -6.76% |
| September 30, 2021 | -125.6% |
| Date | Value |
|---|---|
| June 30, 2021 | -2.30% |
| March 31, 2021 | -16.47% |
| December 31, 2020 | -33.66% |
| September 30, 2020 | 10.08% |
| June 30, 2020 | -38.65% |
| March 31, 2020 | -39.99% |
| December 31, 2019 | -67.63% |
| September 30, 2019 | -19.22% |
| June 30, 2019 | -6.78% |
| March 31, 2019 | -29.57% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-125.6%
Minimum
Sep 2021
10.08%
Maximum
Sep 2020
-28.56%
Average
-16.47%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Flora Growth Corp | -56.23% |
| Tilray Brands Inc | -49.22% |
| Clever Leaves Holdings Inc | -109.6% |
| Seelos Therapeutics Inc | -- |
| Skye Bioscience Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.34% |
| Return on Assets | -11.85% |
| Return on Invested Capital | -17.35% |
| Gross Profit Margin (Quarterly) | 51.08% |
| Operating Margin (Quarterly) | 14.38% |
| Return on Net Operating Assets | -12.92% |